chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Light headed, not functioning in a normal manner, moving slow/ balance, mildly dizzy, and lack the feeling without well being and conscious control
At 1207, PT stated throat started feeling like it was tightening. Pt stood up and begun to have feelings of dizziness. Transferred to private holding/monitoring room by RN.  At 1208,  BP 146/86 on L arm, Pulse ox 24%. Heart 76 bpm. At 1218, Pt states some improvement. Offered water.  at 1221, BP 128/82, heart rate 76bpm, pulse ox 98%.  No more tightness in the throat. Less dizziness. At 1230: BP 138/85 heart rate 74bpm, pulse ox 99%. Pt denies dizziness, has to use bathroom. Sat up to edge of gurney, stood up, and ambulated around room without incident. To bathroom and back to gurney without incident. At 1238: BP 131/84. Heart rate 78bpm. Pulse ox: 98%.  Pt sitting in bed, denies dizziness, states feeling better, and well enough to go home.   Left to home at 1242.
Stomach issues thought at time was stomach bug lasted for 10 days and I was off work all week.  That was the first week of May.  A couple of days later I began having shoulder pain each day worse the arm pain to the extent I could not lift over my head with searing pain tingling numbers it felt like a white hot poker was being stabbed in my right arm bone radiating entire side.  5 weeks of this then a rash and blisters began.  I was called in antiviral as it was the weekend.  I continued to worsen.  My Dr called in pain medication and gabapentin and steroids.  By July 2nd still experiencing intense pain limited use of my right arm.  Seen my Dr again and diagnosed with PHN.  He upped the GABAPENTIN and continued pain meds and said I may have this the rest of my life
Dizziness, loss of vision, cold sweat, chest pain. Vital signs are taken, "Dextro" sample is performed. Everything is normal and after a few minutes sitting, she reports feeling good.
Fever, aches, started overnight after the shot.  Soreness at injection site, localized soreness in armpit (lymph node).  Fever (100.4) lasted one day.  Arm and lymph node tenderness still present (two days).
VSS. Generalized urticaria developed within 24 hours of vaccination. Seen at clinic within 72 hrs of rash development. Urticaria and pruritus very intense. Treated with tapering doses of prednisone and BENADRYL.
This patient complains that her right hand developed an orange discoloration of the palm and interdigital spaces at 8pm on the day of vaccination. She received vaccine in left arm. She denies any other rash or discoloration. Denies using any potential discoloring agents with hand. Has been unable to wash discoloration off. Denies any GI symptoms. Denies jaundice of eyes or yellowing of any other areas of skin. No fasting. No increase in carotenoids. Will be following up with PCP for further evaluation.
This spontaneous report was received from a health professional regarding multiple unspecified patients of unknown age and gender. No historical or concurrent conditions were reported. On an unknown date, the patients were vaccinated with improperly stored GARDASIL (HPV 4) (lot # K011325, expiry: 08-APR-2017), (incorrect product storage). No concomitant medications were reported. The improper storage temperature was 31.9 degrees Fahrenheit for a time frame of 23 hours and 30 minutes. The temperature was back in range. There was no previous temperature excursion. No adverse effects were reported. No Product Quality Complaint (PQC) was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Presented to ED w/ generalized weakness; admitted for COVID-19 pna & UTI; tx w/abx, remedesivir, Vit C, zinc; did not require O2 therapy; dc'd to SNF
Intermittent mild chest pain and episodes of shortness of breath and a ?fluttering heart? sensation over a period of about 1 month after the second dose.
Child developed generalized seizure 1 time ten days after immunization - DTaP, IPV, MMR, HIB, and Flu.
I now have Shingles and see where there are many others reporting the onset of shingles after getting their COVID vaccine.  I will NOT get the second dose
felt like I had pneumonia 24/7; no energy; I had diarrhea; I was feverish really bad; felt a little off; This spontaneous case was reported by an other health care professional and describes the occurrence of PNEUMONIA (felt like I had pneumonia 24/7) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced FEELING ABNORMAL (felt a little off) and PYREXIA (I was feverish really bad). On 16-May-2021, the patient experienced PNEUMONIA (felt like I had pneumonia 24/7) (seriousness criterion medically significant), ASTHENIA (no energy) and DIARRHOEA (I had diarrhea). At the time of the report, PNEUMONIA (felt like I had pneumonia 24/7), ASTHENIA (no energy) and PYREXIA (I was feverish really bad) had not resolved and FEELING ABNORMAL (felt a little off) and DIARRHOEA (I had diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that pneumonia, asthenia, pyrexia and illness were worsened. Events pneumonia and illness caused patient to seek medical care. Patient was sick for about a month.  Treatment information was not provided.  Company comment: This spontaneous case concerns a 49-year-old female patient with no medical history reported, who experienced the unexpected, serious (medically significant) event of pneumonia 2 days after the first dose of mRNA-1273. The patient describes that she had to pause and take a breath during daily activities (such as taking a shower), and that she had influenza like symptoms. Information regarding clinical evaluation, diagnostic tests and treatment provided has not been disclosed. Outcome was reported as not resolved.  The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-646291 (Patient Link).; Sender's Comments: This spontaneous case concerns a 49-year-old female patient with no medical history reported, who experienced the unexpected, serious (medically significant) event of pneumonia 2 days after the first dose of mRNA-1273. The patient describes that she had to pause and take a breath during daily activities (such as taking a shower), and that she had influenza like symptoms. Information regarding clinical evaluation, diagnostic tests and treatment provided has not been disclosed. Outcome was reported as not resolved.  The benefit-risk relationship of mRNA-1273 is not affected by this report.
This was the 2nd Moderna Shot on 2-18-2021.  She received the first shot on 1-22-2021. Patient verbally reported to me that about 4 hours after the shot, she began experiencing severe shocks all over her face and into her left neck and chest area.  This quickly worsened to include her left arm.  That all resolved after a nap.  But when she woke up, and went to the mirror, she noted that her left face was slow and drooping.  She went to the ER.  It was noted that she was having a severe problem with swallowing.  She also was noting severe pain in left external ear canal.  She had obvious severe breakout in the left ear canal - and the immediate area.  She was sent home - and came to my office the next day.  By that time, the symptoms had become much much worse.  She was unable to swallow.  The outbreak in the left ear was much more pronounced.  And her entire left face and left tongue were paralyzed.  She was diagnosed with the Ramsay-Hunt Syndrome - she was unable to talk or swallow.  She was readmitted back into the hospital.
There were no adverse reactions noted. Realized after patient left that vaccine had expired. Patient was called and informed of the mistake.
PT REPORTED A HISTORY OF FAINTING/PASSING OUT AFTER IMMUNIZATIONS BUT STILL WANTED TO RECEIVE HIS 2ND COVID VACCINE , AFTER RECEIVING HIS SHOT HE WAS SITTING DOWN AND SLID OFF THE CHAIR AND ONTO THE FLOOR . I WENT OVER TO PROVIDE ASSISTANCE , SAT HIM BACK UP AND ASKED IF I COULD CALL ANYONE OR 911 FOR HIM WHICH HE AGREED TO . THE EMT"S CAME CHECKED HIS VITAL SIGNS AND HE WAS FINE , THEY ASKED HIM IF HE WANTED TO BE TAKEN TO THE HOSPITAL , HE DECLINED AND JUST WANTED TO GO HOME.
Chills, extreme shaking, fever, delusions, suicidal ideations, extreme emotions, migraine
After receiving the first dose of the Moderna vaccine on 1/4/21 at 8:30 am, all was well and I returned to work.  As the day went on the only encounter I had was soreness at the injection site.  But, the next day, Tuesday 1/5/21 @ around 10:00 in the morning while showering a notice that I had lump that looked to be swollen under my left arm where the injection was administered.  I thought it was the medicine working its way through the body, and would resolve in a few days.  But on today, Thursday 1/7/21 it is still there.  So since I had to work today, I decided to go to Medical Center at my job for someone there to witness what was going on.  Person, from Medical Center gave me the number to the hotline and advised me to call immediately.  So I returned to my floor and placed the call.
R.Ph reported 10 y.o. was given vaccine & 13 days later had a seizure.
Information has been received from a medical assistant concerning a multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not informed. It was reported that on unspecified dates, the patients were vaccinated with improperly stored doses of VARIVAX, lots # L046885, M010484 and L024256, (expiration dates, dosages and therapy routes were not provided). Concurrent conditions were not informed. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information is not expected as no consent for follow up was given.
patient presented to ED with weakness, altered mental status. Admitted to the hospital with urosepsis, acute on chronic kidney injury, elevated lactate and BNP
aching body, could not get out of bed for a day & half;could not raise arm;
Arm became hot and red; Arm became hot and red; This spontaneous case was received on 27-Sep-2021 from other health professional via  Communications (reference number: SEQW21-02839) and concerned a female patient, of an unknown age.   The patient's relevant medical history and concomitant medications were not reported.   On 22-Sep-2021, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose: 0.5 ml, route of administration and anatomical location: not reported) as prevention of seasonal influenza. The batch number reported was 312852 and expiry date 17-Jun-2022.    On the same day, after receiving Fluad Quadrivalent, the patient experienced an adverse site reaction as her arm became hot and red.  The outcome of the events was unknown.   The reporter assessed the events to be related to Fluad Quadrivalent.  The case is linked to cases 202103211 and 202103212 (the same reporter).  Company comment: A patient of an unknown age received Fluad Quadrivalent. On the same day, after receiving Fluad Quadrivalent, the patient's arm became hot and red. Causal role of the suspect vaccine is assessed as possibly related.; Reporter's Comments: The reporter assessed the events to be related to Fluad Quadrivalent, as it was stated the patient experienced an adverse site reaction.; Sender's Comments: A patient of an unknown age received Fluad Quadrivalent. On the same day, after receiving Fluad Quadrivalent, the patient's arm became hot and red. Causal role of the suspect vaccine is assessed as possibly related.
Soreness on the arm where shot administered. Noticed a couple days after still sore issues w/ raising arm or putting sweater on.
Eight hours after the vaccine I got a Migraine and my Asthma kicked up. I had achy joints and muscles and a slight fever. I had a rash on my shoulders, ankles and forearms. It was little spots about six inches. Those symptoms lasted for 36 hours. After that point I had very low Oxygen levels and my Asthma was very severe. My Nebulizer and rescue inhaler were not very effective. It has been almost nine weeks and my Oxygen levels are still lower than normal at 96 or 97.  Before the vaccine my Asthma was controlled and I rarely used the rescue inhaler. I use my rescue inhaler once daily. I am using my Nebulizer once daily. Immediately after the vaccine I was using my Nebulizer four times daily. It is still not near the level of control I had before the vaccine.
Hives / Urticaria appeared later in the week after the 1st vaccine dose, as patches on the back of my upper legs which lasted for a day. Then a few days later more hives appeared at a different location: inner thighs, bilaterally (about 6 inches in diameter, but patchy). Then a few days after that, more hives appeared at my hip creases and elbow creases - all only lasting for about a day. The hive continued to pop-up at different parts of my body at random times, every 1-3 days (on Shoulders, under breasts, belly, calves, back, bottom, neck, arms). Interestingly, areas of my body that had the hives about 2-3 times, seems to show repeat less as time goes on. Last night was the worst expression of this. I have not felt the need to see the doctor, but after last night, I will plan on contacting them. Though the "itchiness" is bearable, it woke me from sleep around 1-2AM. I did not know what was causing it, but I haven't eaten anything new or used new soaps. So I suspect the vaccine might be related.
Swollen, red, itchy, warm to the touch near the area where the vaccine was received
Two minutes after vaccine was give to left arm was painful and swelled about 1" diameter at injection site 2-3 mm out from skin. No redness present.
Mom called 8/08/2002 at 10:00am. Said child had awakened with whelps on lower legs this am and she called Dr. and he ordered Benadryl cream on phone.
Patient wrongly received the orig. Pfizer vaccine INSTEAD of the Pfizer Bi-valent Vaccine.
pt had shots in AM; in afternoon t102.7 R, fussy on & off, didn't want to eat; APAP given & temp went down; MD instructed mom that this was an adverse react & not to get anymore DTP inject again;
Developed suspected pityriasis rosea beginning 5-6 weeks after second dose of Pfizer COVID-19 vaccine. Began with 2cm red patch on left medial chest which exhibited central clearing and slight scale as it progressed. Thought possible tinea and treated with Lotrimin cream but began to see additional smaller lesions over the chest and upper abdomen a few days later. Rash spread down abdomen and circumferentially around trunk. Lesions slightly raised, mildly itchy. Symptoms ongoing. No fever. No lesions on extremities, palms, or soles.
12 hours after receiving the vaccine, I woke up in the middle of the night with severe chills, fever-like symptoms, a headache, and aches all over my body. I also was experiencing a heavy chest and shortness of breath. All but one of the adverse events went away after 24-36 hours - the shortness of breath and shallow breathing have persisted up through today. I am very aware of my breathing and how my chest feels tight, like I'm not getting enough air.
After needle was withdrawn from arm, a large amount of vaccine dripped down pt's arm. Per CDC recommendation, I repeated the dose since the patient received less than the recommended dose, but used approximately 0.25 mL, not the entire dose. The following day, pt reported vomiting.
Patients received vaccine past published expiry date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received vaccine past published expiry date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received vaccine past published expiry date). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patients received vaccine past published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that the affected vial was moved from freezer to the refrigerator on 28-Sep-2021.  Treatment information was not provided.
Patient given 1.8 ml of Pfizer vaccine instead of the recommended 0.3 ml dose.
Vasovagal Syncope; unauthorized age patient, 17 years of age; This spontaneous case was reported by a nurse and describes the occurrence of SYNCOPE (Vasovagal Syncope) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Congenital heart disease NOS since 22-May-2003.    On 01-Mar-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021 at 2:30 PM, the patient experienced SYNCOPE (Vasovagal Syncope) (seriousness criterion medically significant) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age patient, 17 years of age). On 01-Mar-2021, SYNCOPE (Vasovagal Syncope) had resolved. On 01-Mar-2021 at 2:30 PM, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age patient, 17 years of age) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered SYNCOPE (Vasovagal Syncope) to be unlikely related. No further causality assessment was provided for PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age patient, 17 years of age).    No relevant concomitant medications were reported.   The patient did not receive any treatment. The event, SYNCOPE (vasovagal syncope) was an acute episode and recovered quickly within minutes.  Follow-up received on 06-APR-2021 included additional reporter information, date of vaccine administration, patient's race, ethnicity and other relevant medical history, start and dates of product administered and the events, anatomical location, and reporter causality.  This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated syncope reported. The reporter considered SYNCOPE to be unlikely related.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: additional reporter information, date of vaccine administration, patient's race, ethnicity and concurrent condition, additional event - Syncope, onset and stop dates of the event, - Product administered to patient of inappropriate age, injection site, and reporter causality.; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated syncope reported.The reporter considered SYNCOPE to be unlikely related.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Viral encephalitis; Short term memory loss; Combative behavior; Significant cognitive deficit; Not remembering words; Completely incoherent; A spontaneous report was received from a consumer concerning a 78-year-old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced short term memory loss, combative behavior, viral encephalitis, significant cognitive deficit, not remembering words, and completely incoherent.  The patient's medical history, as provided by the reporter, included an unspecified thyroid disorder. Concomitant medications reported included levothyroxine and  levothyroxine sodium.  On 09 Jan 2021, approximately two days prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 11 Jan 2021, the patient began exhibiting short term memory loss and combative behavior. She was completely incoherent, not remembering words, could not name colors or shapes, and her short term memory was gone.   On 15 Jan 2021, the patient saw a neurologist and tests ordered included a doppler and air being blown into her ear.  On 18 Jan 2021, the patient had unspecified bloodwork done. No results were provided.  On 21 Jan 2021, three magnetic resonance imaging (MRI) exams were conducted as well. No results were reported.   On 21 Jan 2021, it was reported the patient's symptoms had not resolved and the patient had since been hospitalized. Her doctors believed she developed viral encephalitis brought on by the COVID vaccine. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The events, short term memory loss, combative behavior, viral encephalitis, significant cognitive deficit, not remembering words, and completely incoherent, were considered not resolved.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
pt recv vax 19SEP95 & was exposed to varicella from sibling who exp breakthrough chicken pox p/vax;17JUL96 pt exp breakthrough case of chicken pox w/multiple red pin point vesicular blisters across groin & torso area;
One 08/10/99, two and one half weeks subsequent to receiving one dose of varicella virus vaccine live, the pt developed varicella rash with itch and less than 50 lesions but greater than 20 lesions. The pt was afebrile. Additional information has been requested.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Mar2021 as dose 1, single (Lot number: EN6205), in right arm, on 27Mar2021 as dose 2, single (Lot number: ER8730), in right arm and on 15Oct2021 as dose 3 (booster), single (Lot number: FF2587) at the age of 32 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Cutaneous lymphoma" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19 which include Paxlovid from 03Aug2022 to 07Aug2022.  Clinical information: The patient had no known allergies. Other medication in 2 weeks was reported as none.  No follow-up attempts are needed. No further information is expected.
Fever ranging from 102-104, headache, fatigued, weak, body aches
Feet got really hot and arms got really cold. She sleeps on her left side and her arm hurt so she couldn't sleep. Shivered and felt cold. Felt better by the morning.
Patient noted to have excessive throat clearing within 15minutes following vaccination.  She reported tingling of her throat and tongue and generalized itching of the arms.  Diphenhydramine administered and symptoms resolved.